However, MDR-induced upregulation of TGF-β and SMAD4 expression was significantly suppressed by PZH treatment, suggesting that PZH suppresses TGF-β pathway in drug-resistant colorectal cancer cells. The gene discussed is SMAD4; the disease is colorectal cancer.